Lactoferricin Research for Bacterial Infections
An evidence-based overview of research examining Lactoferricin in the context of bacterial infections. This page synthesizes findings from peer-reviewed literature.
Research Summary
Lactoferricin has been extensively studied in vitro for antibacterial activity. Research demonstrates broad-spectrum activity against gram-positive and gram-negative bacteria including E. coli, Staphylococcus aureus, and Pseudomonas aeruginosa (Bellamy et al., 1992). Inhibitory concentrations reported in that survey ranged from roughly 0.3 to 150 ug/mL depending on bacterial strain and culture medium. However, all therapeutic efficacy data is preclinical.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Lactoferricin has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.